{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 84,
        "end": 100
      }
    },
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 118,
        "end": 122
      }
    },
    {
      "id": "T4",
      "obj": "Chemical",
      "span": {
        "begin": 127,
        "end": 139
      }
    },
    {
      "id": "T5",
      "obj": "Chemical",
      "span": {
        "begin": 142,
        "end": 145
      }
    },
    {
      "id": "T6",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 169,
        "end": 174
      }
    },
    {
      "id": "T7",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 180,
        "end": 184
      }
    },
    {
      "id": "T8",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 189,
        "end": 194
      }
    },
    {
      "id": "T9",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 197,
        "end": 204
      }
    },
    {
      "id": "T10",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 210,
        "end": 214
      }
    },
    {
      "id": "T11",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 223,
        "end": 230
      }
    },
    {
      "id": "T12",
      "obj": "Chemical",
      "span": {
        "begin": 241,
        "end": 244
      }
    },
    {
      "id": "T13",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 259,
        "end": 264
      }
    },
    {
      "id": "T14",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 269,
        "end": 273
      }
    },
    {
      "id": "T16",
      "obj": "Chemical",
      "span": {
        "begin": 362,
        "end": 365
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "25007187_2",
  "text": "BACKGROUND : The aim of this study is to analyze polymorphisms in genes involved in 6-mercaptopurine detoxification ( TPMT ) ; methotrexate ( MTX ) metabolism including ABCB1 ( or MDR1 ) , ABCC2 , SLC19A1 ( or RFC1 ) , and SLCO1B1 ; and the MTX effect mainly MTHFR and TYMS , and to assess whether these polymorphisms are predictors of treatment toxicity and/or MTX clearance ."
}
